Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04191096
Brief Title: Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)

First Submitted : December 5, 2019
First Submitted that Met QC Criteria : December 5, 2019
First Posted : December 9, 2019

Last Update Submitted that Met QC Criteria : July 6, 2021
Last Update Posted : July 7, 2021